TRVI - Company ID 0001563880
Trevi Therapeutics, Inc. has filed 524 public company documents between 2012 and 2026. The most frequent type is insider trade (192 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Type | Filing | Filed | Period covered | Open |
|---|---|---|---|---|
| 8-K | Major company event | 11mo ago2025-08-07 | 2025-08-07 | View filing |
| SCHEDULE 13G | SCHEDULE 13G | 1y ago2025-07-09 | - | View filing |
| 8-K | Major company event | 1y ago2025-06-17 | 2025-06-11 | View filing |
| 4 | Insider trade | 1y ago2025-06-13 | 2025-06-11 | View filing |
| 4 | Insider trade | 1y ago2025-06-13 | 2025-06-11 | View filing |
| 4 | Insider trade | 1y ago2025-06-13 | 2025-06-11 | View filing |
| 4 | Insider trade | 1y ago2025-06-13 | 2025-06-11 | View filing |
| 4 | Insider trade | 1y ago2025-06-13 | 2025-06-11 | View filing |
| 8-K | Major company event | 1y ago2025-06-04 | 2025-06-03 | View filing |
| 424B5 | Prospectus supplement | 1y ago2025-06-04 | - | View filing |
| 4 | Insider trade | 1y ago2025-06-03 | 2025-05-31 | View filing |
| 4 | Insider trade | 1y ago2025-06-03 | 2025-05-31 | View filing |
| 4 | Insider trade | 1y ago2025-06-03 | 2025-05-31 | View filing |
| 4 | Insider trade | 1y ago2025-06-03 | 2025-05-31 | View filing |
| 4 | Insider trade | 1y ago2025-06-03 | 2025-05-31 | View filing |
| 424B5 | Prospectus supplement | 1y ago2025-06-02 | - | View filing |
| 8-K | Major company event | 1y ago2025-06-02 | 2025-06-02 | View filing |
| 8-K | Major company event | 1y ago2025-06-02 | 2025-06-02 | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 1y ago2025-05-15 | - | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 1y ago2025-05-15 | - | View filing |
| 10-Q | Quarterly report | 1y ago2025-05-08 | 2025-03-31 | View filing |
| 8-K | Major company event | 1y ago2025-05-08 | 2025-05-08 | View filing |
| DEFA14A | Proxy materials | 1y ago2025-04-29 | - | View filing |
| ARS | Annual report to shareholders | 1y ago2025-04-29 | 2024-12-31 | View filing |
| DEF 14A | Proxy statement | 1y ago2025-04-29 | 2025-04-29 | View filing |
| 4 | Insider trade | 1y ago2025-03-26 | 2025-03-25 | View filing |
| 4 | Insider trade | 1y ago2025-03-25 | 2025-03-21 | View filing |
| 144 | Insider sale notice | 1y ago2025-03-21 | - | View filing |
| SCHEDULE 13D/A | SCHEDULE 13D/A | 1y ago2025-03-20 | - | View filing |
| S-8 | Employee stock plan | 1y ago2025-03-18 | - | View filing |
| 10-K | Annual report | 1y ago2025-03-18 | 2024-12-31 | View filing |
| 8-K | Major company event | 1y ago2025-03-18 | 2025-03-18 | View filing |
| 4 | Insider trade | 1y ago2025-03-12 | 2025-03-10 | View filing |
| 4 | Insider trade | 1y ago2025-03-12 | 2025-03-10 | View filing |
| 4 | Insider trade | 1y ago2025-03-12 | 2025-03-10 | View filing |
| 4 | Insider trade | 1y ago2025-03-12 | 2025-03-10 | View filing |
| 4 | Insider trade | 1y ago2025-03-12 | 2025-03-10 | View filing |
| 144 | Insider sale notice | 1y ago2025-03-10 | - | View filing |
| 8-K | Major company event | 1y ago2025-03-10 | 2025-03-10 | View filing |
| 4 | Insider trade | 1y ago2025-02-20 | 2025-02-18 | View filing |
| 4 | Insider trade | 1y ago2025-02-20 | 2025-02-18 | View filing |
| 4 | Insider trade | 1y ago2025-02-20 | 2025-02-18 | View filing |
| 4 | Insider trade | 1y ago2025-02-20 | 2025-02-18 | View filing |
| 4 | Insider trade | 1y ago2025-02-20 | 2025-02-18 | View filing |
| 4 | Insider trade | 1y ago2025-02-20 | 2025-02-18 | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 1y ago2025-02-14 | - | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 1y ago2025-02-14 | - | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 1y ago2025-02-13 | - | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 1y ago2025-02-13 | - | View filing |
| 4 | Insider trade | 1y ago2025-01-10 | 2025-01-07 | View filing |